Abstract
Isocitrate lyase (ICL) plays a pivotal role in the persistence of Mycobacterium tuberculosis in mice by sustaining intracellular infection in inflammatory macrophages. The enzyme allows net carbon gain by diverting acetyl-CoA from β-oxidation of fatty acids into the glyoxylate shunt pathway. Given its potential as a drug target against persistent infections, we solved its structure without ligand and in complex with two inhibitors. Covalent modification of an active site residue, Cys 191, by the inhibitor 3-bromopyruvate traps the enzyme in a catalytic conformation with the active site completely inaccessible to solvent. The structure of a C191S mutant of the enzyme with the inhibitor 3-nitropropionate provides further insight into the reaction mechanism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parrish, N.M., Dick, J.D. & Bishai, W.R. Trends Microbiol. 6, 107–112 (1998).
Mitchison, D.A. J. R. Coll. Physicians Lond. 14, 91–99 (1980).
McKinney, J.D., Jacobs, W.E. & Bloom, B.R. In Emerging infections (eds, Krause, R., Gallin, J.I. & Fauci, A.S.), 51–146 (Academic Press, New York; 1998).
Schaible, U.E., Sturgill-Koszycki, S., Schlesinger, P.H. & Russell, D.G. J. Immunol. 160, 1290–1296 (1998).
Segal, W. In The Mycobacteria: a sourcebook (eds, Kubica, G.P. & Wayne, L.G.), 547–573 (Dekker, New York; 1984).
Wheeler, P.R. & Ratledge, C. J. Gen. Microbiol. 134, 2111–2121 (1988).
Vanni, P., Giachetti, E., Pinzuati, G. & McFadden, B.A. Comp. Biochem. Physiol. 95B, 431–458 (1990).
Hoener zu Bentrup, K., Miczak, A., Swenson, D.L. & Russell, D.G. J. Bacteriol. 181, 7161–7167 (1999).
Graham, J.E. & Clark-Curtiss, J.E. Proc. Natl. Acad. Sci. USA 96, 11554–11559 (1999).
McKinney, J.D. et al. Nature, in the press (2000).
Schloss, J.V. & Cleland, W.W. Biochemistry 21, 4420–4427 (1982).
Ko, Y.H. & McFadden, B.A. Arch. Biochem. Biophys. 278, 373–380 (1990).
Britton, K. et al. Structure Fold. Des. 8, 349–362 (2000).
Matsuoka, M. & McFadden, B.A. J. Bacteriol. 170, 4528–4536 (1988).
Bennett, M.J., Schlunegger, M.P. & Eisenberg, D. Protein Sci. 4, 2455–2468 (1995).
Huang, K., Li, Z., Jia, Y., Dunaway-Mariano, D. & Herzberg, O. Structure Fold. Des. 7, 539–548 (1999).
Hoyt, J.C., Robertson, E.F., Berlyn, K.A. & Reeves, H.C. Biochim. Biophys. Acta 966, 30–35 (1988).
Kyte, J. Mechanism in protein chemistry, 377–378 (Garland, New York; 1995).
Diehl, P. & McFadden, B.A. J. Bacteriol. 176, 927–931 (1994).
Kannan, K.B. et al. Indian J. Lepr. 57, 542–548 (1985).
Rao, G.R. & McFadden, B.A. Arch. Biochem. Biophys. 112, 294–303 (1965).
Wilson, R.B. & Maloy, S.R. 169, 3029–3034 (1987).
Moncla, B.J., Hillier, S.L. & Charnetzky, W.T. J. Bacteriol. 153, 340–344 (1983).
Simon, M.W., Martin, E. & Mukkada, A.J. J. Bacteriol. 135, 895–899 (1978).
Hendrickson, W.A., Horton, J.R. & LeMaster, D.M. EMBO J. 9, 1665–1672 (1990).
Otwinowski, Z. & Minor, W. Methods Enzymol. 276, 307–326 (1997).
Terwilliger, T.C. & Berendzen, J. Acta Crystallogr. D 55, 849–861 (1999).
Brunger, A.T. et al. Acta Crystallogr. D 54, 905–921 (1998).
Navaza, J. Acta Crystallogr. A 50, 157–163 (1994).
Collaborative Computational Project Number 4. Acta Crystallogr. D 50, 760–763 (1994).
Jones, T.A., Zou, J., Kjelgaard, M. & Cowan, S.W. Acta Crystallogr. A 47, 110–119 (1991).
Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M. J. Appl. Crystallogr. 26, 283–291 (1993).
Acknowledgements
The authors thank F.J. Rotella at the SBC beam line 19-ID and W. Schildkamp and G. Navrotski at BioCARS beam line 14 for their help. Use of the Argonne National Laboratory Structural Biology Center beam lines at the Advanced Photon Source was supported by the US Department of Energy, Office of Energy Research. Use of the BioCARS Sector 14 was supported by the NIH, National Center for Research Resources. K.H. zu B. and colleagues were responsible for generating data shown in Fig. 1. This work was supported by the NIH, the Robert A. Welch Foundation and Glaxo Wellcome.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, V., Sharma, S., zu Bentrup, K. et al. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Mol Biol 7, 663–668 (2000). https://doi.org/10.1038/77964
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/77964
This article is cited by
-
Identification of natural potent inhibitors against Mycobacterium tuberculosis isocitrate lyase: an in silico study
Molecular Diversity (2023)
-
Combined utilization of metabolic inhibitors to prevent synergistic multi-species biofilm formation
AMB Express (2022)
-
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development
Molecular Biomedicine (2022)
-
Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase
Scientific Reports (2020)
-
Itaconic acid inhibits growth of a pathogenic marine Vibrio strain: A metabolomics approach
Scientific Reports (2019)